Verizon Communications Inc. officer Kyle Malady filed a Form 144 notice on November 17, 2026, disclosing a proposed sale of 1,100 shares of Verizon common stock on the NYSE through Fidelity Brokerage Services LLC.

Key Highlights

  • Proposed sale: Kyle Malady, an officer of Verizon Communications Inc., proposes to sell 1,100 shares of common stock with an aggregate market value of $50,666.00.
  • Acquisition source: The 1,100 shares were acquired on March 1, 2026, through restricted stock vesting from the issuer, with payment classified as compensation.
  • Approximate sale date: The filing lists the approximate date of sale as November 17, 2026, through broker Fidelity Brokerage Services LLC.
  • 10b5-1 plan: The notice indicates a Rule 10b5-1 trading plan was adopted on May 18, 2026.
  • Prior three-month sales: The filing discloses 13 prior sales of 1,100 shares each by Malady between August 18, 2026, and November 10, 2026, with gross proceeds ranging from $47,223.00 to $56,309.00 per transaction.
  • Shares outstanding: The filing states 4,144,598,336 shares of Verizon common stock were outstanding at the time of the notice.

Malady's Proposed Verizon Share Sale Under Rule 144

According to the Form 144 filed with the U.S. Securities and Exchange Commission on November 17, 2026, Kyle Malady, identified as an officer of Verizon Communications Inc. (NYSE:VZ), intends to sell 1,100 shares of the company's common stock. The filing lists the aggregate market value of the proposed sale at $50,666.00. The shares were acquired on March 1, 2026, via restricted stock vesting directly from the issuer, and the nature of payment is described as compensation.

The filing discloses that the proposed sale is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, on the New York Stock Exchange. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kyle Malady. The filing also notes that Malady is relying on a Rule 10b5-1 trading plan adopted on May 18, 2026.

In the section covering securities sold during the past three months, the filing lists 13 separate transactions, each involving 1,100 shares of Verizon common stock sold by Kyle Malady between August 18, 2026, and November 10, 2026. Gross proceeds from those transactions ranged from $47,223.00 to $56,309.00 per sale, according to the filing. The total shares of Verizon common stock outstanding are reported in the filing as 4,144,598,336.

What Was Disclosed

Verizon Communications Inc. officer Kyle Malady filed a Form 144 notice proposing the sale of 1,100 common shares, acquired through restricted stock vesting, with an aggregate market value of $50,666.00, under a Rule 10b5-1 plan adopted May 18, 2026.